Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Verorab
Active Ingredient: Rabies vaccine, Wistar PM/WI 38-1503-3M 2.5IU
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Sanofi Pasteur SA, Val-De-Reuil, France
Sanofi Pasteur SA, Marcy L’Etoile, France
Note: This renewed consent is valid for two years from 27 January 2013.
Dated this 25th day of October 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).